These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11023607)

  • 1. Targeting apoptosis by hydroxymethylacylfulvene in combination with gamma radiation in prostate tumor cells.
    Woynarowska BA; Roberts K; Woynarowski JM; MacDonald JR; Herman TS
    Radiat Res; 2000 Oct; 154(4):429-38. PubMed ID: 11023607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of neurotensin receptor 1 selectively sensitizes prostate cancer to ionizing radiation.
    Valerie NC; Casarez EV; Dasilva JO; Dunlap-Brown ME; Parsons SJ; Amorino GP; Dziegielewski J
    Cancer Res; 2011 Nov; 71(21):6817-26. PubMed ID: 21903767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential cytotoxicity and induction of apoptosis in tumor and normal cells by hydroxymethylacylfulvene (HMAF).
    Woynarowska BA; Woynarowski JM; Herzig MC; Roberts K; Higdon AL; MacDonald JR
    Biochem Pharmacol; 2000 May; 59(10):1217-26. PubMed ID: 10736422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha1-adrenoceptor antagonists radiosensitize prostate cancer cells via apoptosis induction.
    Cuellar DC; Rhee J; Kyprianou N
    Anticancer Res; 2002; 22(3):1673-9. PubMed ID: 12168853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosensitization of hormone-refractory prostate cancer cells by gossypol treatment.
    Akagunduz O; Karaca B; Atmaca H; Uzunoglu S; Karabulut B; Sanli UA; Haydaroglu A; Uslu R
    J BUON; 2010; 15(4):763-7. PubMed ID: 21229643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis and clonogenic cell death in PC3 human prostate cancer cells after treatment with gamma radiation and suramin.
    Palayoor ST; Bump EA; Teicher BA; Coleman CN
    Radiat Res; 1997 Aug; 148(2):105-14. PubMed ID: 9254728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adamantanyl-histone deacetylase inhibitor H6CAHA exhibits favorable pharmacokinetics and augments prostate cancer radiation sensitivity.
    Konsoula Z; Cao H; Velena A; Jung M
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1541-8. PubMed ID: 21277099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of prostate cancer radiosensitization by androgen deprivation.
    Pollack A; Salem N; Ashoori F; Hachem P; Sangha M; von Eschenbach AC; Meistrich ML
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1002-7. PubMed ID: 11704324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosine enhances apoptosis of radiation-resistant prostate cancer cells.
    Nava VE; Cuvillier O; Edsall LC; Kimura K; Milstien S; Gelmann EP; Spiegel S
    Cancer Res; 2000 Aug; 60(16):4468-74. PubMed ID: 10969794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects on DNA integrity and apoptosis induction by a novel antitumor sesquiterpene drug, 6-hydroxymethylacylfulvene (HMAF, MGI 114).
    Woynarowski JM; Napier C; Koester SK; Chen SF; Troyer D; Chapman W; MacDonald JR
    Biochem Pharmacol; 1997 Dec; 54(11):1181-93. PubMed ID: 9416969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genistein potentiates the radiation effect on prostate carcinoma cells.
    Hillman GG; Forman JD; Kucuk O; Yudelev M; Maughan RL; Rubio J; Layer A; Tekyi-Mensah S; Abrams J; Sarkar FH
    Clin Cancer Res; 2001 Feb; 7(2):382-90. PubMed ID: 11234894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancer.
    Eiseman JL; Rogers FA; Guo Y; Kauffman J; Sentz DL; Klinger MF; Callery PS; Kyprianou N
    Cancer Res; 1998 Nov; 58(21):4864-70. PubMed ID: 9809992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of radiation response by histone deacetylase inhibition.
    Chinnaiyan P; Vallabhaneni G; Armstrong E; Huang SM; Harari PM
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):223-9. PubMed ID: 15850925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxyurea and trimidox enhance the radiation effect in human pancreatic adenocarcinoma cells.
    Leyden D; Ahmed N; Hassan HT
    Anticancer Res; 2000; 20(1A):133-8. PubMed ID: 10769645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redox modulation of human prostate carcinoma cells by selenite increases radiation-induced cell killing.
    Husbeck B; Peehl DM; Knox SJ
    Free Radic Biol Med; 2005 Jan; 38(1):50-7. PubMed ID: 15589371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of irofulven monotherapy and in combination with mitoxantrone or docetaxel against human prostate cancer models.
    Van Laar ES; Weitman S; MacDonald JR; Waters SJ
    Prostate; 2004 Apr; 59(1):22-32. PubMed ID: 14991863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External beam radiation therapy for clinically localized prostate cancer: when and how we optimize with concurrent hormonal deprivation.
    Koontz BF; Lee WR
    Arch Esp Urol; 2011 Oct; 64(8):858-64. PubMed ID: 22052767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in prostate-specific antigen (PSA) level correlate with growth inhibition of prostate cancer cells treated in vitro with a novel anticancer drug, irofulven.
    Woynarowska BAHigdon AL; Muñoz RM; Bushong P; Waters SJ
    Invest New Drugs; 2001; 19(4):283-91. PubMed ID: 11561687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MLN8054, a small molecule inhibitor of aurora kinase a, sensitizes androgen-resistant prostate cancer to radiation.
    Moretti L; Niermann K; Schleicher S; Giacalone NJ; Varki V; Kim KW; Kopsombut P; Jung DK; Lu B
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1189-97. PubMed ID: 21514073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro studies on the modification of low-dose hyper-radiosensitivity in prostate cancer cells by incubation with genistein and estradiol.
    Hermann RM; Wolff HA; Jarry H; Thelen P; Gruendker C; Rave-Fraenk M; Schmidberger H; Christiansen H
    Radiat Oncol; 2008 Jul; 3():19. PubMed ID: 18625043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.